Monoamine oxidase, hydrogen peroxide, and Parkinson's disease.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D046508:Culture Techniques; D004298:Dopamine / Q000031:analogs & derivatives / Q000633:toxicity; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism*; D006878:Hydroxides / Q000378:metabolism; D006892:Hydroxydopamines / Q000633:toxicity; D017665:Hydroxyl Radical; D008252:Macaca fascicularis; D008995:Monoamine Oxidase / Q000378:metabolism*; D009474:Neurons / Q000201:enzymology; D016627:Oxidopamine; D010300:Parkinson Disease / Q000201:enzymology*; D010302:Parkinson Disease, Secondary / Q000201:enzymology; D011725:Pyridines / Q000633:toxicity; D013481:Superoxides / Q000378:metabolism
D006878:Hydroxides; D006892:Hydroxydopamines; D011725:Pyridines; D013481:Superoxides; D017665:Hydroxyl Radical; C006532:6-aminodopamine; D016627:Oxidopamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D006861:Hydrogen Peroxide; D008995:Monoamine Oxidase; D004298:Dopamine